These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 24729702)
1. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor. Yin F; Guo S; Gan Y; Zhang X Int J Nanomedicine; 2014; 9():1665-76. PubMed ID: 24729702 [TBL] [Abstract][Full Text] [Related]
2. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication. Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731 [TBL] [Abstract][Full Text] [Related]
3. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections. Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354 [TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Li H; Song JH; Park JS; Han K Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749 [TBL] [Abstract][Full Text] [Related]
5. Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders. Charnvanich D; Vardhanabhuti N; Kulvanich P AAPS PharmSciTech; 2010 Jun; 11(2):832-42. PubMed ID: 20464536 [TBL] [Abstract][Full Text] [Related]
6. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying. Saboti D; Maver U; Chan HK; Planinšek O J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981 [TBL] [Abstract][Full Text] [Related]
7. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing. Santana H; García G; Vega M; Beldarraín A; Páez R PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746 [TBL] [Abstract][Full Text] [Related]
8. Liposomal dry powders as aerosols for pulmonary delivery of proteins. Lu D; Hickey AJ AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866 [TBL] [Abstract][Full Text] [Related]
9. Development of (Inhalable) Dry Powder Formulations of AS01 AboulFotouh K; Xu H; Moon C; Williams RO; Cui Z Int J Pharm; 2022 Jun; 622():121825. PubMed ID: 35577037 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human epidermal growth factor-loaded liposomes and transferosomes for dermal delivery: Development, characterization, and cytotoxicity evaluation. Doustvaghe YK; Haeri A; Sisakht MM; Amirkhani MA; Vatanpour H Drug Dev Res; 2024 Aug; 85(5):e22234. PubMed ID: 39041350 [TBL] [Abstract][Full Text] [Related]
11. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles. Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908 [TBL] [Abstract][Full Text] [Related]
12. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying. Seville PC; Kellaway IW; Birchall JC J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985 [TBL] [Abstract][Full Text] [Related]
13. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying. D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019 [TBL] [Abstract][Full Text] [Related]
15. Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor. Li H; An JH; Park JS; Han K Arch Pharm Res; 2005 Aug; 28(8):988-94. PubMed ID: 16178428 [TBL] [Abstract][Full Text] [Related]
16. Preparation of dry reconstituted liposomal powder by freeze-drying at room temperature. Benjakul R; Panyarachun B; Sarisuta N J Liposome Res; 2011 Mar; 21(1):28-37. PubMed ID: 20387991 [TBL] [Abstract][Full Text] [Related]
17. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813 [TBL] [Abstract][Full Text] [Related]
18. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Jain SK; Gupta Y; Jain A; Rai K Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926 [TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. Maa YF; Ameri M; Shu C; Payne LG; Chen D J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078 [TBL] [Abstract][Full Text] [Related]
20. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]